Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elke Hartmann

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Frontiers in Veterinary Science|October 28, 2022
Rein tension in harness trotters during on-track exerciseAgneta Egenvall, Anna Byström, Mette Pökelmann, et al.
American Journal of Nephrology|September 13, 2021
Direct Blood Pressure-Independent Anti-Fibrotic Effects by the Selective Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone in Progressive Models of Kidney FibrosisKaroline Droebner, Mira Pavkovic, Manuel Grundmann, et al.
Kidney Diseases (Basel, Switzerland)|July 2, 2019
A Novel Model of Chronic Kidney Disease in Rats: Dietary Adenine in Combination with Unilateral NephrectomyCristina Muñoz Abellán, Sandra Mangold-Gehring, Sina Micus, et al.
Journal of Cardiovascular Pharmacology|March 14, 2014
Finerenone, a novel selective nonsteroidal mineralocorticoid receptor antagonist protects from rat cardiorenal injuryPeter Kolkhof, Martina Delbeck, Axel Kretschmer, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 4, 2022
Urinary miRNA Profiles in Chronic Kidney Injury-Benefits of Extracellular Vesicle Enrichment and miRNAs as Potential Biomarkers for Renal Fibrosis, Glomerular Injury, and Endothelial DysfunctionBarbara Petzuch, Agnès Bénardeau, Lucas Hofmeister, et al.
American Journal of Nephrology|June 10, 2021
Effects of Finerenone Combined with Empagliflozin in a Model of Hypertension-Induced End-Organ DamagePeter Kolkhof, Elke Hartmann, Alexius Freyberger, et al.
Archives of Toxicology|May 25, 2002
Sensitive detection of the endocrine effects of the estrogen analogue ethinylestradiol using a modified enhanced subacute rat study protocol (OECD Test Guideline no. 407)Peter Andrews, Alexius Freyberger, Elke Hartmann, et al.
International Journal of Molecular Sciences|August 7, 2021
Assessing the Use of the sGC Stimulator BAY-747, as a Potential Treatment for Duchenne Muscular DystrophyShalini Murali Krishnan, Johannes Nordlohne, Lisa Dietz, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 8, 2010
Mineralocorticoid receptor-mediated DNA damage in kidneys of DOCA-salt hypertensive ratsNicole Schupp, Peter Kolkhof, Nina Queisser, et al.
Plos One|January 29, 2020
Effect of work on body language of ranch horses in BrazilPedro Henrique Esteves Trindade, Elke Hartmann, Linda J Keeling, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Frontiers in Veterinary Science|October 28, 2022
Rein tension in harness trotters during on-track exerciseAgneta Egenvall, Anna Byström, Mette Pökelmann, et al.
American Journal of Nephrology|September 13, 2021
Direct Blood Pressure-Independent Anti-Fibrotic Effects by the Selective Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone in Progressive Models of Kidney FibrosisKaroline Droebner, Mira Pavkovic, Manuel Grundmann, et al.
Kidney Diseases (Basel, Switzerland)|July 2, 2019
A Novel Model of Chronic Kidney Disease in Rats: Dietary Adenine in Combination with Unilateral NephrectomyCristina Muñoz Abellán, Sandra Mangold-Gehring, Sina Micus, et al.
Journal of Cardiovascular Pharmacology|March 14, 2014
Finerenone, a novel selective nonsteroidal mineralocorticoid receptor antagonist protects from rat cardiorenal injuryPeter Kolkhof, Martina Delbeck, Axel Kretschmer, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 4, 2022
Urinary miRNA Profiles in Chronic Kidney Injury-Benefits of Extracellular Vesicle Enrichment and miRNAs as Potential Biomarkers for Renal Fibrosis, Glomerular Injury, and Endothelial DysfunctionBarbara Petzuch, Agnès Bénardeau, Lucas Hofmeister, et al.
American Journal of Nephrology|June 10, 2021
Effects of Finerenone Combined with Empagliflozin in a Model of Hypertension-Induced End-Organ DamagePeter Kolkhof, Elke Hartmann, Alexius Freyberger, et al.
Archives of Toxicology|May 25, 2002
Sensitive detection of the endocrine effects of the estrogen analogue ethinylestradiol using a modified enhanced subacute rat study protocol (OECD Test Guideline no. 407)Peter Andrews, Alexius Freyberger, Elke Hartmann, et al.
International Journal of Molecular Sciences|August 7, 2021
Assessing the Use of the sGC Stimulator BAY-747, as a Potential Treatment for Duchenne Muscular DystrophyShalini Murali Krishnan, Johannes Nordlohne, Lisa Dietz, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 8, 2010
Mineralocorticoid receptor-mediated DNA damage in kidneys of DOCA-salt hypertensive ratsNicole Schupp, Peter Kolkhof, Nina Queisser, et al.
Plos One|January 29, 2020
Effect of work on body language of ranch horses in BrazilPedro Henrique Esteves Trindade, Elke Hartmann, Linda J Keeling, et al.
Pageof 3